HERLEV, Denmark, May 16, 2025 /CNW/ -- Nordic Bioscience introduces nordicEndotrophin™, a fully automated high-precision assay that selectively quantifies the intact 77-amino-acid Endotrophin ...

Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signalling Completes unique suite of rapid, scalable pain-related sodium channel ...

Nordic Bioscience, a Danish biomarker company headquartered in Herlev and engaged in biomarker development using unique neoepitope technology, has introduced nordicEndotrophin, a fully automated ...

Metrion Biosciences (Metrion), the specialist preclinical contract research organisation (CRO) and a global leader in ion channel services, announced the launch of its validated, high-throughput ...

"Researchers have long sought a reliable, blood-based solution to track brain-derived tau pathology," said Dr. Yuling Luo, CEO, Founder and Chairman of Alamar Biosciences. "By integrating assays ...

Screening of a large panel of patient-derived organoids is enabled using Crown Bioscience’s unique assay-ready (AR) organoid technology. Recent posters presented at the AACR annual meeting and ...

SAN DIEGO--(BUSINESS WIRE)--Sapient, a leader in multi-omics discovery, has partnered with Alamar Biosciences ... plex assays using Alamar’s NULISA™ platform and ARGO® HT system.

Meridian Bioscience, Inc., a leading global provider ... had granted clearance for the company’s new Curian® Shiga Toxin assay. This assay joins Curian HpSA® and Curian Campy as Meridian ...

Metrion Biosciences, today announced the launch of its validated, high-throughput NaV1.9 screening assay to advance discovery and development of novel pain therapeutics. Validated drug discovery assay ...

Metrion Biosciences ("Metrion"), the specialist preclinical ... high-throughput NaV1.9 screening assay to advance discovery and development of novel pain therapeutics. Leveraging over a decade ...